Herlev and Gentofte Hospital ( Site 0501)

Copenhagen, Capital Region 2730

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) — Recruiting now
• A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) — Stopped early